New WHO malaria plan to reduce disease burden by 40pc
GENEVA, May 21, 2015
World Health Organisation (WHO) member states have agreed to a new global malaria strategy for 2016-30 and approved the organization’s proposed programme budget for 2016-17.
The strategy aims to reduce the global disease burden by 40 per cent by 2020, and by at least 90 per cent by 2030, said a statement.
It also aims to eliminate malaria in at least 35 new countries by 2030, it said.
Between 2000 and 2013, the global malaria mortality rate dropped by 47 per cent. A major expansion of the WHO-recommended core package of measures – vector control, chemoprevention, diagnostic testing and treatment – has proved both cost effective and efficient.
Nevertheless, millions of people are still unable to access malaria prevention and treatment, and most cases and deaths continue to go unregistered and unreported. In 2013, malaria killed an estimated 584 000 people.
The new strategy aims to build on recent successes to radically reduce this figure. Developed in close consultation with endemic countries and partners, the strategy provides a comprehensive framework so countries can develop tailored programmes that will sustain and accelerate progress towards malaria elimination, said the statement.
It comprises three key elements: ensuring universal access to malaria prevention, diagnosis and treatment; accelerating efforts towards elimination and attainment of malaria-free status; and strengthening malaria surveillance.
It emphasises the importance of innovation and research, and the critical need for political commitment, sustainable financing, strong health systems, and collaboration across different sectors.
Meanwhile, the proposed programme budged for 2016-17 of $4.3 billion includes a $236 million increase over the 2014-15 programme budget requirement to meet the needs of countries; leverage the experience gained during the Ebola outbreak; address emerging priorities such as antimicrobial resistance, health and the environment, malaria and viral hepatitis; and implement resolutions passed by the Assembly and WHO’s Regional Committees.
The additional funds will also be used to further strengthen transparency, improve risk management and enhance accountability. - TradeArabia News Service